Page 3 - Tscan Therapeutics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tscan therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tscan Therapeutics Inc Today - Breaking & Trending Today

TScan Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating TCR-T Therapy for the Treatment of Solid Tumors

TScan Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating TCR-T Therapy for the Treatment of Solid Tumors
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Gavin Macbeath , Maghan Meyers , Heather Savelle , Chrystalu Louis , Securities Exchange , Tscan Therapeutics Inc , Company Immunobank , Tscan Solid Tumor Program , Company Phase , Globe Newswire Tscan Therapeutics Inc , Chief Executive , Chief Medical , Solid Tumor , Private Securities Litigation Reform Act , Securities Exchange Act , Financial Condition , Annual Report ,

abrdn plc Invests $1.17 Million in TScan Therapeutics, Inc. (NASDAQ:TCRX)

Abrdn plc acquired a new stake in TScan Therapeutics, Inc. (NASDAQ:TCRX – Free Report) during the 4th quarter, Holdings Channel.com reports. The firm acquired 200,000 shares of the company’s stock, valued at approximately $1,166,000. Separately, Pale Fire Capital SE bought a new stake in shares of TScan Therapeutics during the 3rd quarter valued at $42,000. […] ....

United States , Tscan Therapeutics Inc , Holdings Channel , Free Report , Pale Fire Capital , Get Free Report , Visit Holdingschannel , Therapeutics Daily , Tscan Therapeutics , Nasdaq Tcrx , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

TScan Therapeutics (NASDAQ:TCRX) Earns Outperform Rating from Wedbush

Wedbush restated their outperform rating on shares of TScan Therapeutics (NASDAQ:TCRX – Free Report) in a research report released on Tuesday, Benzinga reports. They currently have a $10.00 price target on the stock. Separately, HC Wainwright reissued a buy rating and issued a $15.00 price objective on shares of TScan Therapeutics in a research note […] ....

United States , Tscan Therapeutics Inc , Letko Brosseau Associates Inc , Cannon Global Investment Management , Free Report , Therapeutics Stock , Get Free Report , Global Investment Management , Pale Fire Capital , Therapeutics Daily , Tscan Therapeutics , Nasdaq Tcrx , Reiterated Rating ,

TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional Shares

TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional Shares
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , New York , Maghan Meyers , Heather Savelle , Hc Wainwright Co , Globe Newswire Tscan Therapeutics Inc , Morgan Stanley Co , Td Securities United States , Needham Company , Prospectus Department , Exchange Commission , Tscan Therapeutics Inc , Morgan Stanley , Therapeutics Announces Exercise , Underwriter Option , Purchase Additional , Sci Capital ,

TScan Therapeutics Announces Exercise of Underwriters'

WALTHAM, Mass., April 24, 2024 (GLOBE NEWSWIRE) TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the. ....

United States , New York , Heather Savelle , Maghan Meyers , Hc Wainwright Co , Morgan Stanley , Tscan Therapeutics Inc , Exchange Commission , Prospectus Department , Td Securities United States , Needham Company , Morgan Stanley Co , Globe Newswire Tscan Therapeutics Inc , Sci Capital , Nasdaq Tcrx , Tscan Therapeutics ,